GOT1 and pancreatic ductal adenocarcinoma: In addition, the proliferation of PDAC cells is also inhibited upon selective inhibition of GOT1 expression in tumor cells, and these phenomena suggest that targeting GOT1 may be a novel approach for the treatment of pancreatic ductal carcinoma [10].